FDA Launches Web-Based PMTA Forms to Streamline Tobacco Product Applications
The U.S. Food and Drug Administration (FDA) has introduced fully web-based versions of four key regulatory forms for premarket tobacco product applications (PMTAs) and Substantial Equivalence (SE) Reports. This update to the CTP Portal Next Generation (CTP Portal NextGen) allows manufacturers to complete, validate, and submit Forms FDA 4057, 4057a, 3965, and 3965a entirely online.
The new system offers step-by-step guidance, real-time automatic validation, and collaborative drafting features, aiming to reduce administrative burdens and improve submission accuracy. While updated PDF versions remain available for download and submission via the Document Control Center or eSubmitter, the FDA has set a deadline: starting January 2, 2026, applicants using PDFs must use the latest versions or risk their applications being refused.
This rollout is part of a phased upgrade to the CTP Portal NextGen, which launched in early 2025. The FDA prioritized PMTA and SE forms due to their high usage volume, with web-based forms for other submissions like Exemption Requests and ingredient listings to follow. The agency encourages stakeholders to utilize the new system to enhance the efficiency and transparency of the review process.
- Read more: FDA Uses Agentic AI to Speed Up Tobacco PMTA Reviews
- Press release: FDA Launches Web-Based Tobacco Premarket Application Forms to Enhance Submission Process
- UK Tobacco and Vapes Act: The Crucial Next Phase of Regulation - June 17, 2026
- Chile Plans 52.6% Vape Tax Hike to Match Cigarettes - June 17, 2026
- Cook Islands Airport Vaping: Police Warn of Tougher Action - June 17, 2026
